Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Awarded NIH Grant for Alzheimer s Disease Whole Genome Study

NEW YORK, Sept. 13 (GenomeWeb News) - Perlegen Sciences said today that it has been awarded a grant from the National Institute on Aging to conduct a whole-genome association study in order to find the genetic determinants of Alzheimer's disease.

 

According to the company, the study will involve study the use of an oligonucleotide array-based genotyping platform to genotype over 1.5 million single nucleotide polymorphisms across the genome in late-onset Alzheimer's disease patients, as well as controls.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.